RS
Rajesh Sivan
About Rajesh Sivan
Data last updated:
Rajesh Sivan is a Director at Revaba Infertility Clinics Private Limited (since 2023), Director at Meskhenet Healthcare Private Limited (since 2021) and Director at Chaithanya Integrated Healthcare (India) Private Limited (since 2022), and holds 4 more current directorships. The companies operate in Healthcare. The 7 current companies with reported revenue have a combined latest revenue of ₹212 Cr; the largest is Revaba Infertility Clinics Private Limited at ₹50.36 Cr (FY 2025). Earlier, Rajesh Sivan was an Additional Director at Asian Institute Of Nephrology And Urology Private Limited (2024) and Director at Neonates Critical Care Foundation (2019–2023) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Revaba Infertility Clinics Private Limited U85310MH2017PTC441191 | Director | 11 Aug 2023 | 2017 | ₹50.36 Cr (FY 2025) | Active |
 Meskhenet Healthcare Private Limited U85100CH2021PTC043709 | Director | 11 Nov 2021 | 2021 | ₹46.65 Cr (FY 2025) | Active |
 Chaithanya Integrated Healthcare (India) Private Limited U85110MH2008PTC458229 | Director | 12 Sep 2022 | 2008 | ₹39.69 Cr (FY 2025) | Active |
 Asian Institute Of Nephrology And Urology (Siliguri) Private Limited U85300MH2019PTC466715 | Director | 24 Jul 2024 | 2019 | ₹27.07 Cr (FY 2025) | Active |
| Asian Institute Of Nephrology And Urology (Chennai) Private Limited U85100MH2017PTC466706 | Additional Director | 18 Dec 2025 | 2017 | ₹19.55 Cr (FY 2025) | Active |
| Asian Institute Of Nephrology And Urology (Vizag) Private Limited U85100MH2018PTC466707 | Director | 31 Jul 2024 | 2018 | ₹19.50 Cr (FY 2025) | Active |
 Origin International Fertility Centre Private Limited U85100MH2007PTC171739 | Director | 29 Jun 2022 | 2007 | ₹8.73 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Asian Institute Of Nephrology And Urology Private Limited U85110MH2011PTC466714 | Additional Director | 22 Mar 2024 | 2011 | ₹223 Cr (FY 2025) | Active |
| Neonates Critical Care Foundation U85100KA2018NPL119871 | Director | 12 Jul 2019 | 2018 | ₹1.50 Cr (FY 2025) | Active |
 Svas Med Private Limited U85100MH2010PTC462967 | Director | 26 Feb 2021 | 2010 | ₹16.85 Cr (FY 2025) | Active |
 Motherhood Fertility Private Limited U74999MH2016PTC374639 | Director | 01 Oct 2019 | 2016 | ₹2,000 (FY 2023) | Amalgamated |
 Nova Medical Centers Ncr Region Private Limited U85110MH2010PTC376910 | Director | 14 Aug 2020 | 2010 | ₹44.4 Lakh (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajesh Sivan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Sivan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Sivan
Rajesh Sivan currently holds 7 directorships: Revaba Infertility Clinics Private Limited (Director, since 11 Aug 2023, revenue ₹50.36 Cr (FY 2025)); Meskhenet Healthcare Private Limited (Director, since 11 Nov 2021, revenue ₹46.65 Cr (FY 2025)); Chaithanya Integrated Healthcare (India) Private Limited (Director, since 12 Sep 2022, revenue ₹39.69 Cr (FY 2025)); Asian Institute Of Nephrology And Urology (Siliguri) Private Limited (Director, since 24 Jul 2024, revenue ₹27.07 Cr (FY 2025)); Asian Institute Of Nephrology And Urology (Chennai) Private Limited (Additional Director, since 18 Dec 2025, revenue ₹19.55 Cr (FY 2025)); and 2 more.
Rajesh Sivan was first appointed on 12 Jul 2019 as Director at Neonates Critical Care Foundation. The most recent appointment on record is 18 Dec 2025 at Asian Institute Of Nephrology And Urology (Chennai) Private Limited.
The 7 current companies of Rajesh Sivan that report revenue have a combined latest revenue of ₹212 Cr: Revaba Infertility Clinics Private Limited ₹50.36 Cr (FY 2025); Meskhenet Healthcare Private Limited ₹46.65 Cr (FY 2025); Chaithanya Integrated Healthcare (India) Private Limited ₹39.69 Cr (FY 2025); Asian Institute Of Nephrology And Urology (Siliguri) Private Limited ₹27.07 Cr (FY 2025); Asian Institute Of Nephrology And Urology (Chennai) Private Limited ₹19.55 Cr (FY 2025); and 2 more.
Rajesh Sivan held 5 earlier board appointments: Asian Institute Of Nephrology And Urology Private Limited (Additional Director, 22 Mar 2024 to 16 May 2024); Neonates Critical Care Foundation (Director, 12 Jul 2019 to 02 Jun 2023); Svas Med Private Limited (Director, 26 Feb 2021 to 14 May 2021); Motherhood Fertility Private Limited (Director, from 01 Oct 2019); Nova Medical Centers Ncr Region Private Limited (Director, from 14 Aug 2020).
The current boards of Rajesh Sivan's companies include Jayesh Sunilbhai Amin (Revaba Infertility Clinics Private Limited), Kumar Shobhit Agarwal (Revaba Infertility Clinics Private Limited), Vishal Bali (Revaba Infertility Clinics Private Limited), Neeraj Kumar (Meskhenet Healthcare Private Limited), Poonam Garg (Meskhenet Healthcare Private Limited), Venkatraman Vijayarathna (Meskhenet Healthcare Private Limited), among others.